Imaging agents for the chemokine receptor 4 (CXCR4)

被引:71
|
作者
Kuil, Joeri [1 ,2 ]
Buckle, Tessa [1 ]
van Leeuwen, Fijs W. B. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Radiol, NL-2300 RC Leiden, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; BREAST-CANCER METASTASIS; SMALL-MOLECULE INHIBITOR; ANTI-HIV ACTIVITY; ANTAGONIST CTCE-9908; RHEUMATOID-ARTHRITIS; SELECTIVE-INHIBITION; HEMATOPOIETIC STEM; ENTRY INHIBITORS; AGONIST PEPDUCIN;
D O I
10.1039/c2cs35085h
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The interaction between the chemokine receptor 4 (CXCR4) and stromal cell-derived factor-1 (SDF-1, also known as CXCL12) is a natural regulatory process in the human body. However, CXCR4 over-expression is also found in diseases such as cancer, where it plays a role in, among others, the metastatic spread. For this reason it is an interesting biomarker for the field of diagnostic oncology, and therefore, it is gaining increasing interest for applications in molecular imaging. Especially "small-molecule" imaging agents based on T140, FC131 and AMD3100 have been extensively studied. SDF-1, antibodies, pepducins and bioluminescence have also been used to visualize CXCR4. In this critical review reported CXCR4 targeting imaging agents are described based on their affinity, specificity and biodistribution. The level wherein CXCR4 is up-regulated in cancer patients and its relation to the different cell lines and animal models used to evaluate the efficacy of the imaging agents is also discussed (221 references).
引用
收藏
页码:5239 / 5261
页数:23
相关论文
共 50 条
  • [1] CXCR4 chemokine receptor antagonists: perspectives in SCLC
    Burger, Jan A.
    Stewart, David J.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (04) : 481 - 490
  • [2] Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents
    Tsutsumi, Hiroshi
    Tanaka, Tomohiro
    Ohashi, Nami
    Masuno, Hiroyuki
    Tamamura, Hirokazu
    Hiramatsu, Kenichi
    Araki, Takanobu
    Ueda, Satoshi
    Oishi, Shinya
    Fujii, Nobutaka
    BIOPOLYMERS, 2007, 88 (02) : 279 - 289
  • [3] Clinical relevance of chemokine receptor CXCR4
    Gebura, Katarzyna
    Bogunia-Kubik, Katarzyna
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2012, 66 : 252 - 266
  • [4] Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors
    Shim, Hyunsuk
    Oishi, Shinya
    Fujii, Nobutaka
    SEMINARS IN CANCER BIOLOGY, 2009, 19 (02) : 123 - 134
  • [5] Drug Discovery Research Targeting the CXC Chemokine Receptor 4 (CXCR4)
    Choi, Won-Tak
    Duggineni, Srinivas
    Xu, Yan
    Huang, Ziwei
    An, Jing
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (03) : 977 - 994
  • [6] CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment
    Bao, Shunshun
    Darvishi, Mohammad
    Amin, Ali
    Al-Haideri, Maysoon T.
    Patra, Indrajit
    Kashikova, Khadisha
    Ahmad, Irfan
    Alsaikhan, Fahad
    Al-qaim, Zahraa Haleem
    Al-Gazally, Moaed E.
    Kiasari, Bahman Abedi
    Tavakoli-Far, Bahareh
    Sidikov, Akmal A.
    Mustafa, Yasser Fakri
    Akhavan-Sigari, Reza
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7945 - 7968
  • [7] The chemokine receptor CXCR4 as a therapeutic target for several diseases
    Tamamura, Hirokazu
    Tsutsumi, Hiroshi
    Fujii, Nobutaka
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (09) : 989 - 995
  • [8] A future perspective on the development of chemokine receptor CXCR4 antagonists
    Tamamura, Hirokazu
    Tsutsumi, Hiroshi
    Nomura, Wataru
    Tanaka, Tomohiro
    Fujii, Nobutaka
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (10) : 1155 - 1166
  • [9] Structure-Based Development of Antagonists for Chemokine Receptor CXCR4
    Zhang, Chongqian
    Hou, Tingjun
    Feng, Zhiwei
    Li, Youyong
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2013, 9 (01) : 60 - 75
  • [10] 64Cu-AMD3100-A novel imaging agent for targeting chemokine receptor CXCR4
    Jacobson, Orit
    Weiss, Ido D.
    Szajek, Lawrence
    Farber, Joshua M.
    Kiesewetter, Dale O.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (04) : 1486 - 1493